Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
about
Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesThe potential of polymeric micelles in the context of glioblastoma therapy.Drug and gene delivery across the blood-brain barrier with focused ultrasoundUptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier modelEGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interferenceTargeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study.A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue.Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil.Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenograftsPreclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.Drug transport to brain with targeted nanoparticles.Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.Agile delivery of protein therapeutics to CNSExploiting the tumor phenotype using biodegradable submicron carriers of chemotherapeutic drugs.Imaging of cells and nanoparticles: implications for drug delivery to the brain.Risks from accidental exposures to engineered nanoparticles and neurological health effects: a critical review.Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimagingCircumventing tumor resistance to chemotherapy by nanotechnologyCell-mediated drug delivery.Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment.Functionalized nano-graphene oxide particles for targeted fluorescence imaging and photothermy of glioma U251 cellsNew technologies for drug delivery across the blood brain barrier.Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumorBrain-targeting study of stearic acid-grafted chitosan micelle drug-delivery systemPEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.Nano-enabled delivery of diverse payloads across complex biological barriers.Bioadhesive properties of pegylated nanoparticles.Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicinePharmacokinetic consequences of pegylation.In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery.Targeted pharmaceutical nanocarriers for cancer therapy and imagingNanoparticles in modern medicine: state of the art and future challenges.Magnetoelectric 'spin' on stimulating the brain.Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery.Polymeric nanoparticles for the drug delivery to the central nervous system.A macrophage-nanozyme delivery system for Parkinson's disease.
P2860
Q26850868-D85B77B9-3053-4402-87F0-C6C483AC1CC8Q27693205-923D5AF9-E623-44BD-9C6C-2EC8F8A882A8Q28080611-611FA510-1E8F-4FBA-AB75-A558CB81738FQ28481345-659EA56D-FE6C-44EE-832E-2E6D4AC68BECQ28486127-EAAF02F0-16C8-44E8-8B80-9250167C967AQ30406070-33B4C7EB-DD79-45FB-B309-A07BC00E5C2BQ30541682-93CABA88-B4A5-4946-A730-80954DC688D7Q30620922-24EA35D5-E401-4ED0-B19C-7C1F0E1FB05BQ33464397-2820F01F-32B0-4C74-BB20-3EAFAE6887B4Q33554366-1D53BB91-9EF3-4469-BE72-A910D65879FBQ33666026-084ED517-7117-4636-867D-B8799A44FAF7Q33726019-EAAE8836-C9B6-4163-BC52-BE081F66E849Q33864330-365060CB-40A1-4DA8-B499-7EFE6034110BQ33985140-46A4D324-9F23-498A-AC37-85F0C37CA2D8Q33996836-67954E8D-6CA3-4687-9946-0BAB25402C2BQ34079647-EFC6D8F9-607E-4157-A0FC-05F6645DC46BQ34284213-03D4027D-1286-4819-AD2A-0A7CB59164B4Q34340761-6ED7FC38-1C3C-43E4-BC97-F381684C5301Q34468073-169504BA-5DDB-41AC-80F3-A154BDC33DE5Q34611770-3871F0E9-F2F3-4BD9-9F2A-06A886E33683Q34618357-733C6494-BA09-4088-A9CC-42963B5DE30DQ34709440-BD12E7EF-CFDD-449A-AF1F-47F70D53A550Q35556934-B03906BA-883D-414A-BDF1-5FCDBDF8D6DFQ35619914-1A032480-A178-402C-BD3E-66730F933463Q35768308-8576A123-717B-4BF9-A38B-FDC055B94BCDQ35898349-580BBBC2-E073-47F4-9445-AFF1DBECFD10Q36066170-D11BA078-1CAF-4470-8058-59A4A2C8BD8DQ36093926-7DB4F11A-A60E-4CE6-9EBA-64C9E9687CB6Q36094371-A8069E76-8921-4229-8C28-3CAE93ABE068Q36307467-C8F10BAA-75A3-43C9-8155-4E9B656E31AFQ36316693-BC0681F6-C8A3-4953-9B5F-34FD1E3CB79AQ36403289-83AF294C-63B0-4ACB-B45F-3F2A7D0105DCQ36604526-B1FA2244-E50B-4A87-8E0E-6B839F757D43Q36656012-8C36A848-9B79-4D8E-8712-5BCC3F432B7AQ36871933-230E219C-7215-4CA3-9453-DA6DDDA398BBQ36920457-554E8CFC-4D15-49DA-8AA1-1479C142BD64Q37013410-C02649C9-7808-44C0-A5A6-F8F617287CC8Q37015849-9C1434D7-FC86-424F-8580-D930BE6A97DAQ37076360-74913332-82F5-499F-A606-BD3A71516DD6Q37179637-87ADF551-897E-41C7-A14F-2146AFA813C8
P2860
Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Long-circulating PEGylated pol ...... ug carrier for brain delivery.
@ast
Long-circulating PEGylated pol ...... ug carrier for brain delivery.
@en
type
label
Long-circulating PEGylated pol ...... ug carrier for brain delivery.
@ast
Long-circulating PEGylated pol ...... ug carrier for brain delivery.
@en
prefLabel
Long-circulating PEGylated pol ...... ug carrier for brain delivery.
@ast
Long-circulating PEGylated pol ...... ug carrier for brain delivery.
@en
P2093
P356
P1476
Long-circulating PEGylated pol ...... ug carrier for brain delivery.
@en
P2093
B Gouritin
D Desmaële
J D'Angelo
J P Andreux
P304
P356
10.1023/A:1010931127745
P577
2001-08-01T00:00:00Z